Streetbeat News

Products Services

LXRX

Lexicon Pharmaceuticals has completed screening for its Phase 2B study of LX9211, a treatment for diabetic peripheral neuropathic pain, and expects to complete enrollment ahead of schedule. Top-line data is now anticipated in Q1 2025, earlier than previously expected.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 12:03 pm

ZVSA

ZyVersa Therapeutics shares rose after publishing data in Aging Cell, showing obesity's link to neuroinflammation and neurodegenerative diseases.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 12:02 pm

NVDA

NVIDIA Corp (NASDAQ:NVDA) reached a new all-time high, closing at $143.71, driven by strong demand for its AI-focused GPUs. Jim Cramer and analyst Dan Ives expressed bullish sentiments, highlighting Nvidia's dominance in the AI sector. Despite a slight premarket dip, the stock is up 198.34% year-to-date.

Portfolio Pulse from Kaustubh Bagalkote

October 22, 2024 | 12:00 pm

GRMN

Garmin has acquired Lumishore, a UK-based company specializing in premium LED lighting systems for vessels. The financial terms of the acquisition were not disclosed. Lumishore's team will join Garmin's global workforce.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 11:59 am

ATHA

Athira Pharma is set to present results from its Phase 2/3 LIFT-AD clinical trial of Fosgonimeton, a treatment for Alzheimer's disease. This presentation could provide insights into the drug's efficacy and impact Athira's stock price.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 11:57 am

IRTC

iRhythm Technologies' shares rose following FDA clearance for design changes to its Zio AT device.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 11:52 am

J

Jacobs has been selected by the US Bureau of Reclamation to design and build the San Juan Lateral Water Treatment Plant in New Mexico, a key component of the Navajo-Gallup Water Supply Project, costing $267 million.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 11:47 am

DASH

FI

Fiserv has announced a collaboration with DoorDash to integrate financial services into DoorDash's digital platform. This partnership aims to enhance the financial capabilities available to DoorDash's users.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 11:44 am

LXEO

Lexeo Therapeutics announced that interim data from its ongoing Phase 1/2 trial of LX1001 will be presented as a late-breaking oral presentation at the CTAD Conference. This highlights the potential significance of the trial results.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 11:38 am

BIIB

Biogen is set to present new data from its felzartamab clinical development program at Kidney Week 2024, including conclusive Phase 2 IGNAZ study results for IgA nephropathy.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 11:37 am